JPRN-UMIN000003900已完成2 期
Phase II trial of axilla treatment after primary chemotherapy for breast cancer patients with sentinel lymph node metastases - Axilla treatment after chemotherapy for sentinel node-positive breast cancer patients
Japanese Society for Sentinel Node Navigation Surgery0 个研究点目标入组 98 人开始时间: 2010年7月14日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 98
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •Breast cancer patient during pregnancy Bilateral breast cancer Primary endocrine therapy
研究者
相似试验
已完成
2 期
Phase II trial of early secondary treatment with nibolumab for non-small cell lung cancernon-small cell lung cancerJPRN-UMIN000030457Fujita Health University School30
尚未招募
不适用
Phase II study of adjuvant therapy of alternate day oral therapy with S-1 for patients with curative resected biliary tract cancerbiliary tract cancerJPRN-UMIN000021459Gastrointestinal and pediatric surgery Tokyo medical university40
已完成
2 期
Permissive Hypercapnia, Alveolar Recruitment and Limited Airway Pressures reduce injury in Acute Respiratory Distress Syndrome.Acute respiratory distress syndrome.Respiratory - Other respiratory disorders / diseasesACTRN12607000465459Intensive Care Unit, Alfred Hospital20
进行中（未招募）
1 期
Clinical trial to investigate the efficacy of treatment combination with gemcitabine and pazopanib in patients with inoperable locally advanced or metastatic gallbladder and bile duct cancerMedDRA version: 14.1Level: LLTClassification code 10017620Term: Gallbladder carcinomaSystem Organ Class: 100000004864Inoperable locally advanced or metastatic cancer of the biliary tree (cholangiocarcinoma and gallbladder carcinoma)MedDRA version: 14.1Level: LLTClassification code 10008593Term: CholangiocarcinomaSystem Organ Class: 100000004864MedDRA version: 14.1Level: LLTClassification code 10004655Term: Biliary carcinomaSystem Organ Class: 100000004864EUCTR2012-001705-24-GRHellenic Cooperative Oncology Group46
进行中（未招募）
1 期
TRIAL TO EVALUATE CHEMOTHERAPY WITH CAPECITABINE OR CAPECITABINE PLUS MITOMYCIN C IN ADVANCED BILIARY TRACT CANCERocally advanced or metastatic adenocarcinoma of the biliary tract (intra or extra-hepatic biliary ducts, gallbladder, Ampulla of Vater).MedDRA version: 14.1Level: LLTClassification code 10025734Term: Malignant neoplasm of biliary tract, part unspecifiedSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-002002-70-ITFONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR57